Metabolic Disposition and Pharmacokinetics of [14C]-Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects
Titel:
Metabolic Disposition and Pharmacokinetics of [14C]-Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects
Auteur:
Sadler, Brian M. Chittick, Gregory E. Polk, Ronald E. Slain, Douglas Kerkering, Thomas M. Studenberg, Scott D. Lou, Yu Moore, Katy H. P. Woolley, Joseph L. Stein, Daniel S.